GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genscript Biotech Corp (OTCPK:GNNSF) » Definitions » Other Long Term Assets

GNNSF (Genscript Biotech) Other Long Term Assets : $3,826.1 Mil (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Genscript Biotech Other Long Term Assets?

Genscript Biotech's other long-term assets for the quarter that ended in Dec. 2024 was $3,826.1 Mil.

Genscript Biotech's quarterly other long-term assets increased from Dec. 2023 ($263.2 Mil) to Jun. 2024 ($266.2 Mil) and increased from Jun. 2024 ($266.2 Mil) to Dec. 2024 ($3,826.1 Mil).

Genscript Biotech's annual other long-term assets increased from Dec. 2022 ($108.2 Mil) to Dec. 2023 ($263.2 Mil) and increased from Dec. 2023 ($263.2 Mil) to Dec. 2024 ($3,826.1 Mil).

Genscript Biotech Other Long Term Assets Historical Data

The historical data trend for Genscript Biotech's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genscript Biotech Other Long Term Assets Chart

Genscript Biotech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 38.17 48.81 108.15 263.24 3,826.08

Genscript Biotech Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 108.15 182.17 263.24 266.21 3,826.08

Genscript Biotech Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Genscript Biotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genscript Biotech Corp (OTCPK:GNNSF) » Definitions » Other Long Term Assets
Comparable Companies
HKSE:01877 HKSE:02696 HKSE:09995 HKSE:06855 HKSE:09969 HKSE:09606 HKSE:01952 HKSE:02162 HKSE:02171 HKSE:02617 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:UCB XBRU:ARGX ONC XKRX:068270 BNTX
Traded in Other Exchanges
01548:Hong Kong G51:Germany G51:Germany
Address
No. 28, Yongxi Road, Jiangning Science Park, Jiangsu Province, Nanjing, CHN, 211100
Website
https://www.genscript.com
Genscript Biotech Corp is a China-based provider of life science research services and products. The firm is known for its gene synthesis capabilities, a widely used service by academics, biotech companies, and pharmaceutical companies around the world. The company's business segments include Life-science services and products, Biologics development services, Industrial synthetic biology products, and the Operation unit. The company generates the majority of its revenue from the life-science services and products unit, which provides comprehensive research services and products, which are widely used and are fundamental to life-science research and application. Geographically, the company generates the majority of its revenue from the United States of America, followed by Mainland China.